Roadmap
From proof of concept to clinical readiness
A development path structured around responsible engineering, validation planning, regulatory strategy and strategic partnerships.
Proof of concept
Initial feasibility work and technical development, including preclinical experiments in Lyon, have supported continued platform development.
IP protection
Cobodoc controls a surgical-instrument IP portfolio (VitalDrill®, VitalFlap®, VitalFix™) and is preparing additional filings for its next-generation robotic assistance platform.
Prototype refinement
Ongoing engineering focuses on prototype refinement, system architecture, software development and hardware integration.
Validation planning
Planned activities include preclinical evaluation, usability assessment, risk analysis, design documentation and quality-system preparation.
Regulatory strategy
Preparation of a regulatory strategy to support future clinical-readiness activities, subject to development and validation.
Partnerships & funding
Engagement with strategic partners, accelerators, robotics and deep-tech investors, and non-dilutive funding such as NIH SBIR/STTR programs.

How we work
Medical-device discipline from day one
Design documentation
Traceable requirements, design inputs and outputs, prepared with future quality-system requirements in mind.
Risk management
Risk analysis integrated into engineering choices, in line with recognised medical-device practice.
Usability
Usability assessment with clinicians to shape a system that fits real surgical workflows.
Preclinical evaluation
Structured preclinical evaluation planning before any clinical activity.
Help us reach the next milestones
Your support can fund IP filings, prototype refinement, validation planning, regulatory strategy, quality-system preparation and U.S. development.
Regulatory notice. Cobodoc’s robotic assistance platform is under development and is not commercially available. Future clinical use, indications, performance characteristics and benefits remain subject to development, validation, clinical evaluation and regulatory clearance.
